Latest Benign Prostatic Hyperplasia (BPH) News
Prostatic urethral lift is minimally invasive and, according to a new study, the procedure's beneficial effects are durable out to 3 years.
Neither drug decreased operative time, prostate volume, or weight of gland resected.
Overall, men with LUTS showed remarkably poor knowledge about their symptoms.
Ten years after the laser procedure, no reoperation was needed for 95% of patients treated for symptomatic benign prostatic hyperplasia.
Men who reported having severe lower urinary tract symptoms (LUTS) had a 64% increased risk of the malignancy compared with those who reported no LUTS.
Outcomes were significantly better in men with large prostates, however.
Depression is prevalent among men with benign prostatic hyperplasia (BPH).
Men with lower levels of sedentary time had a significantly lower risk of benign prostatic hyperplasia (BPH).
Vancouver Symptom Score linked to bullying victimization and perpetrator scores
Metabolic syndrome linked to severity of LUTS; symptoms improve after bariatric surgery
From 2000 to 2011, transurethral resection of the prostate for benign prostatic hyperplasia (BPH) decreased and laser procedures increased.
UroLift offers minimally-invasive treatment of benign prostatic hyperplasia (BPH) without risk of sexual dysfunction.
Sitting to urinate is associated with an improved urodynamic profile in lower urinary tract symptoms (LUTS).
Many urologists not uniformly adhering to AUA guidelines for the management of benign prostatic hyperplasia/lower urinary tract symptoms.
NEPHROLOGY & UROLOGY NEWS
- Acute Kidney Injury (AKI)
- Chronic Kidney Disease (CKD)
- Contrast Nephropathy
- Cardiovascular Disease (CVD)
- Diabetic Nephropathy
- End-stage Renal Disease (ESRD)
- Lupus Nephritis
- Peritoneal Dialysis
- Secondary Hyperparathyroidism (SHPT)